Glenmark Pharmaceuticals has informed about a Press Release dated March 23, 2016, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Raloxifene Hydrochloride Tablets USP, 60 mg’.
The above information is a part of company’s filings submitted to BSE.